Description

The CD57 blood test is offered to evaluate and follow patients suspected of having or diagnosed with chronic Lyme disease. It has been reported that people with chronic Lyme disease have a decreased number of natural killer cells (NK cells), as defined by the CD57 marker.  It is the most cost effective way to assess if someone is dealing with a vector borne disease or illness.